Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

UBS Maintains Buy on Equifax, Raises Price Target to $297

Author: Benzinga Newsdesk | September 15, 2025 08:40am
UBS analyst Kevin Mcveigh maintains Equifax (NYSE:EFX) with a Buy and raises the price target from $287 to $297.

Posted In: EFX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist